Related Experiment Video
Updated: Jul 17, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
[C-reactive protein in cardiovascular diseases]
Wojciech Lubas1, Krzysztof Gutkowski
1Oddział Chorób Wewnetrznych, z Pododdziałem Intensywnej, Opieki Kardiologicznej Szpitala Ministerstwa, Spraw Wewnqtrznych i Administracji, w Rzeszowie. intmsw@mp.pl
Przeglad Lekarski
|January 6, 2007
Summary
Many heart attacks and strokes occur in people with normal cholesterol. High-sensitivity C-reactive protein (hs-CRP) testing may help identify cardiovascular disease risk beyond cholesterol levels.
Area of Science:
- Cardiology
- Biochemistry
- Inflammation Research
Context:
- Cardiovascular diseases (CVDs) pose a significant health burden.
- Elevated LDL-cholesterol is a known risk factor, but many CVD events occur in individuals with normal levels.
- This highlights the need for additional risk assessment markers.
Purpose:
- To review current knowledge on the association between C-reactive protein (CRP) and cardiovascular diseases.
- To emphasize the role of inflammation in atherogenesis.
- To explore the utility of CRP as a biomarker for CVD risk stratification.
Summary:
- C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to inflammation.
- Traditionally used for inflammatory and neoplastic diseases, CRP measurement is increasingly recognized for its role in CVD.
- High-sensitivity CRP (hs-CRP) assays enable precise assessment of the link between inflammation, atherogenesis, and CVD complications.
Impact:
- CRP measurement, particularly hs-CRP, offers a valuable tool for identifying individuals at high risk for cardiovascular events.
- Integrating CRP into risk assessment protocols can improve patient management and preventative strategies.
- This review provides a foundation for understanding CRP's clinical significance in cardiology.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...